DKSH Sees Multinationals Scaling Back Thailand Business As Government Looks To Curb Costs
This article was originally published in PharmAsia News
DKSH works extensively in emerging and frontier markets in Asia and has a solid ground-level view on commercial prospects. Bernd Lepper, regional vice president for Thailand, Malaysia and Singapore, spoke to PharmAsia News about prospects in Thailand as the government moves to curb spending on universal coverage schemes.
You may also be interested in...
Thailand’s military junta has made few moves to tackle reimbursement reforms since a coup in May. But the appointment of a cabinet this month may signal action on health care spending levels.
Thai Researchers, MMV Launch Preclinical Look For New Anti-Malaria Compound Targeting Mutant Enzymes
Research into anti-malarial drug effectiveness in Thailand prompts a pre-clinical look at novel compound.
Thailand struggles to tackle reimbursement reforms as political tension grips the country following a military coup last week. Still the civil service continues to take decisions on budget and spending plans, but domestic and multinational firms are keeping a wary eye on developments.